|
|
Volumn 67, Issue 2, 2010, Pages 94-
|
|
HIV treatment guidelines revised
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
ATAZANAVIR PLUS RITONAVIR;
DARUNAVIR PLUS RITONAVIR PLUS TENOFOVIR;
EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
LAMIVUDINE PLUS ZIDOVUDINE;
LOPINAVIR PLUS RITONAVIR;
RALTEGRAVIR PLUS TENOFOVIR PLUS EMTRICITABINE;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CARDIOVASCULAR DISEASE;
CD4+ T LYMPHOCYTE;
CELL COUNT;
CONSENSUS;
DISEASE ASSOCIATION;
DISEASE TRANSMISSION;
EARLY INTERVENTION;
GENE MUTATION;
GENETIC SCREENING;
GENOTYPE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFLAMMATION;
MENTAL DETERIORATION;
NEOPLASM;
NONHUMAN;
NOTE;
ORGAN INJURY;
PHENOTYPE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK REDUCTION;
TREATMENT RESPONSE;
|
|
EID: 75149124554
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news100006 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|